Is Sermorelin Legal in Massachusetts? How to Access It Legally
HealthRX.com
No sermorelin product is FDA-approved in the US today
Key numbers
- 0.05 mg/ampuleGeref 0.05 mg/ampule, approved for testing pituitary growth hormone secretionSource: federalregister.gov, as cited Nov 7, 2026
- 0.5 mgGeref 0.5 mg vial, approved for idiopathic growth hormone deficiency in childrenSource: federalregister.gov, as cited Nov 7, 2026
- 1 mgGeref 1 mg vial, approved for idiopathic growth hormone deficiency in childrenSource: federalregister.gov, as cited Nov 7, 2026
See the public record for Sermorelin
At a glance
- Federal status / No FDA-approved sermorelin product; Geref approvals withdrawn in 2009 [1]
- What is sold now / Compounded sermorelin, which is not FDA-approved [2]
- Prescription / Required for the state-licensed-pharmacy pathway under federal compounding conditions [3]
- FDA safety-risk list / Sermorelin is not on it [4]
- Outsourcing-facility list / Sermorelin acetate is in category 1, meaning under evaluation; the list marks it as a component of FDA-approved drugs. This is not FDA approval of sermorelin [5]
- Massachusetts rules / Not covered on this page; state law is separate from federal status
- Sport / Prohibited at all times by WADA [6]
What is sermorelin's federal status?
Sermorelin is a growth hormone-releasing hormone analogue: it prompts the pituitary to release growth hormone, and it is not growth hormone itself [7].
It reached the US market as Geref under two approvals: a 0.05 mg/ampule product approved in December 1990 for testing the pituitary's ability to secrete growth hormone, and 0.5 mg and 1 mg vials approved in September 1997 for treating idiopathic growth hormone deficiency in children with growth failure [1]. The manufacturer discontinued both in 2008 and FDA withdrew the approvals effective June 18, 2009; in March 2013 FDA determined that Geref was not withdrawn for reasons of safety or effectiveness [1][8]. Geref was never approved for adults, anti-aging, weight loss or athletic performance [1].
Is compounded sermorelin legal?
Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they reach patients [2]. A state-licensed pharmacy may compound a human drug only if it meets a list of conditions, one of which is a valid patient-specific prescription; outsourcing facilities register with FDA, follow current good manufacturing practice and report adverse events [3].
Where sermorelin sits on FDA and HHS lists:
- It is not on FDA's list of bulk substances that may present significant safety risks, content dated 04/22/2026 [4].
- On the nomination list for outsourcing facilities, updated March 21, 2025, sermorelin acetate is in category 1 (under evaluation) and is marked as a component of FDA-approved drugs [5].
- It appears in no category on FDA's list for state-licensed pharmacies, updated May 14, 2026, and it is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [9][10].
Questions worth asking
What about Massachusetts rules?
FDA approval, federal compounding eligibility and Massachusetts pharmacy law are separate questions. This page covers the federal facts above and does not describe Massachusetts law, so it cannot confirm that any particular compounded sermorelin product is legal in the state.
Does the sport status matter?
Yes, if you compete. WADA's 2026 Prohibited List names sermorelin in S2.2.4 among growth hormone releasing factors, prohibited at all times, in and out of competition, as a non-Specified Substance [6]. It is also named in the 2027 List, in force January 1, 2027 [11].
Frequently asked questions
Is sermorelin legal in Massachusetts?
Can I buy sermorelin without a prescription?
Is compounded sermorelin FDA-approved?
Can athletes use sermorelin?
References
Show all 11 referencesHide references
- Federal Register :: Request Access.
- Official web page.
- Human Drug Compounding Laws | FDA.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Official web page.
- World Anti-Doping Agency.